medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2018, Number 2

<< Back Next >>

An Med Asoc Med Hosp ABC 2018; 63 (2)

Immunohematological follow-up: post-transplant of hematopoietic stem cells with bidirectional ABO incompatibility for acute lymphoblastic leukemia

Canché MKA, Ramírez CAJ, Bautista JJ, Núñez MME

Language: Spanish
References: 11
Page: 117-121
PDF size: 184.47 Kb.


ABSTRACT

Hematopoietic stem cell transplantation aims to reestablish the bone marrow and immune function of patients with malignant and benign hematologic disorders. One of the methods used to assess the graft status is the determination of chimerism. The immunohematological follow-up of a patient who underwent bidirectional ABO incompatible hematopoietic stem cell transplantation for acute lymphoblastic leukemia is presented for the reader to understand the relevance of blood group determination and adequate transfusion practices in these patients in order to avoid hemolytic transfusion reactions and loss of the graft.


REFERENCES

  1. Gaytán-Morales F. Trasplante de células progenitoras hematopoyéticas (TCPH) en pediatría. GAMO. 2013; 12 (3): 174-181.

  2. Oliveros-Alvear JW, Sandoval-Carrasco C, Cires-Drouet RS, Blum-Maridueña MA, Tafur-Chang AJ. Trasplante de células hematopoyéticas. Revista Medicina. 2003; 9 (2): 174-185.

  3. Lennard AL, Jackson GH. Stem cell transplantation. BMJ. 2000; 321 (7258): 433-437.

  4. Fabricius WA, Ramanathan M. Review on haploidentical hematopoietic cell transplantation in patients with hematologic malignancies. Adv Hematol. 2016; 2016: 5726132.

  5. Martinez-Alvarez JC, Arrazola-Garcia A. El papel del sistema HLA en el transplante de células progenitoras Hematopoyéticas. Rev Mex Med Trans. 2009; 2 (Supl 1): S38-S42.

  6. Rowley SD, Donato ML, Bhattacharyya P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2011; 46 (9): 1167-1185.

  7. Gómez E, Sánchez E, Pedraza M, Pizzuto J. Incompatibilidad ABO en trasplante de células hematopoyéticas. Revista de Hematología. 2001; 2: 55-58.

  8. Daniel-Johnson J, Schwartz J. How do I approach ABO-incompatible hematopoietic progenitor cell transplantation? Transfusion. 2011; 51 (6): 1143-1149.

  9. Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant. 2004; 34 (1): 1-12.

  10. Pérez C, Alfaro J, Larrondo M. Estudio de quimerismo: aplicación en pacientes con trasplante alogénico de progenitores hematopoyéticos. Rev Hosp Clin Univ Chil. 2006; 17: 129-134.

  11. Ruiz-Argüelles GJ, Bordes-Aznar J, Díaz-Caballero N, Ruiz-Delgado GJ. La importancia del quimerismo en medicina. Gac Med Mex. 2004; 140 (5): 573-575.




2020     |     www.medigraphic.com